NeoGenomics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
NeoGenomics, Inc. (NEO) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 45.10% for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-25.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2022-02-25
- NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2021 was 45.10%, a 5.62% increase from fiscal 2020.
- NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2020 was 42.70%, a 1.16% decline from fiscal 2019.
- NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2019 was 43.20%, a 0.47% increase from fiscal 2018.
- NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2018 was 43.00%, a 12.24% decline from fiscal 2017.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month |
|---|---|---|
| 2021-12-31 | 45.10% 10-K · filed 2022-02-25 | |
| 2020-12-31 | 42.70% 10-K · filed 2022-02-25 | |
| 2019-12-31 | 43.20% 10-K · filed 2022-02-25 | |
| 2018-12-31 | 43.00% 10-K · filed 2021-02-25 | |
| 2017-12-31 | 49.00% 10-K · filed 2020-02-28 | |
| 2016-12-31 | 54.00% 10-K · filed 2019-02-26 | |
| 2016-06-30 | 55.00% 10-Q · filed 2016-08-05 | |
| 2015-12-31 | 51.00% 10-K · filed 2018-03-13 | |
| 2014-12-31 | 50.00% 10-K · filed 2017-03-14 | |
| 2013-12-31 | 46.00% 10-K · filed 2016-04-18 | |
| 2012-12-31 | 51.00% 10-K · filed 2015-03-03 | |
| 2011-12-31 | 55.00% 10-K · filed 2014-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |